RiverGlades Family Offices’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$252K Hold
4,000
0.12% 97
2026
Q1
$302K Buy
+4,000
New +$285K 0.18% 71
2025
Q3
$235K Hold
4,000
0.14% 82
2025
Q2
$233K Buy
+4,000
New +$226K 0.15% 80
2024
Q3
Sell
-4,000
Closed -$204K 86
2024
Q2
$204K Hold
4,000
0.16% 77
2024
Q1
$233K Hold
4,000
0.19% 72
2023
Q4
$200K Hold
4,000
0.16% 74
2023
Q3
$247K Hold
4,000
0.22% 67
2023
Q2
$236K Hold
4,000
0.21% 68
2023
Q1
$295K Hold
4,000
0.27% 57
2022
Q4
$292K Buy
+4,000
New +$316K 0.27% 56
2022
Q2
$319K Hold
4,000
0.3% 55
2022
Q1
$416K Hold
4,000
0.31% 53
2021
Q4
$301K Hold
4,000
0.22% 67
2021
Q3
$259K Hold
4,000
0.2% 70
2021
Q2
$242K Hold
4,000
0.19% 72
2021
Q1
$216K Buy
+4,000
New +$218K 0.18% 74

Other funds holding NTR

RiverGlades Family Offices's NTR Position: Q2 2026 in Review

RiverGlades Family Offices held its Nutrien (NTR) position steady in Q2 2026 at 4,000 shares worth $252K. The position accounts for 0.12% of the portfolio, ranked #97.

RiverGlades Family Offices first reported a position in NTR in Q1 2021 and has held it in 17 quarters since. The position peaked at $416K in Q1 2022. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • RiverGlades Family Offices held 4,000 shares of Nutrien worth $252K as of Q2 2026.
  • RiverGlades Family Offices left its Nutrien share count unchanged in Q2 2026.
  • Nutrien made up 0.12% of RiverGlades Family Offices's portfolio in Q2 2026, its #97 holding.
  • RiverGlades Family Offices first reported a position in Nutrien in Q1 2021 and has held it in 17 quarters since.
  • RiverGlades Family Offices's Nutrien position peaked at $416K in Q1 2022.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on RiverGlades Family Offices's 13F filing for Q2 2026, filed 10 Aug 2026.